Overview
?
Payton Nyquvest
See more contacts
Offices of Other Health Practitioners
,
Pharmaceutical and Medicine Manufacturing
,
Ambulatory Health Care Services
,
Health Care and Social Assistance
,
Psychotherapist, except M.D.
See All Industries Extracts of botanicals: powdered, pilular, solid, or fluid
See Fewer Industries
See All Industries Extracts of botanicals: powdered, pilular, solid, or fluid
See Fewer Industries
Child Care Services
,
Community Food and Housing, and Emergency and Other Relief Services
,
Continuing Care Retirement Communities and Assisted Living Facilities for the Elderly
,
General Medical and Surgical Hospitals
,
Home Health Care Services
,
Individual and Family Services
,
Medical and Diagnostic Laboratories
,
Nursing Care Facilities (Skilled Nursing Facilities)
View more , Offices of Dentists , Offices of Physicians , Other Ambulatory Health Care Services , Other Residential Care Facilities , Outpatient Care Centers , Psychiatric and Substance Abuse Hospitals , Residential Intellectual and Developmental Disability, Mental Health, and Substance Abuse Facilities , Specialty (except Psychiatric and Substance Abuse) Hospitals Vocational Rehabilitation Services
View fewer
View more , Offices of Dentists , Offices of Physicians , Other Ambulatory Health Care Services , Other Residential Care Facilities , Outpatient Care Centers , Psychiatric and Substance Abuse Hospitals , Residential Intellectual and Developmental Disability, Mental Health, and Substance Abuse Facilities , Specialty (except Psychiatric and Substance Abuse) Hospitals Vocational Rehabilitation Services
View fewer
?
?
Actual
$17.34 million
Actual
256.95%
$24
AUG
?
?
Toronto:NUMI
Contacts
Get in Touch with 10 Principals* and 3 Contacts
-
Payton NyquvestExecutive Chairman of the Board
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of August 31, 2023 (12 month period) in USD
Annual Revenue 2023
$17.34 million
USD
Actual
1 USD = 1.3371 CAD
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net Operating Cash | -$17 | -$20 | -$12 |
| Net Investing Cash | -$0 | $0 | -$1 |
| Net Financing Cash | -$1 | $0 | $55 |
| Net Change in Cash | -$18 | -$20 | $43 |
| Cash at Beginning of Period | $25 | $44 | $1 |
| Cash at End of Period | $6 | $25 | $44 |
| Capital Expenditure | -$0 | -$1 | -$0 |
| Assets (mil) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $6 | $25 | $44 |
| Accounts Receivable | $1 | $1 | $0 |
| Inventories | $ | $ | $0 |
| Other Current Assets | $1 | $1 | $1 |
| Asset Summary | |||
| Total Current Assets | $9 | $27 | $46 |
| Tangible Fixed Assets | $7 | $9 | $2 |
| Intangible Assets | $ | $0 | $ |
| Total Assets | $24 | $53 | $64 |
| Liabilities (mil) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $2 | $2 | $1 |
| Short-Term Debt | $0 | $0 | $ |
| Other Current Liabilities | $1 | $1 | $0 |
| Liability Summary | |||
| Total Current Liabilities | $3 | $3 | $1 |
| Long-Term Debt | $0 | $0 | $ |
| Other Long-Term Liabilities | $ | $ | $ |
| Total Liabilities | $8 | $9 | $2 |
| Stakeholder's Equity (mil) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Equity | |||
| Common Stock | $84 | $82 | $66 |
| Retained Earnings | -$87 | -$65 | -$31 |
| Equity Summary | |||
| Total Equity | $11 | $31 | $45 |
| Shares Outstanding | 266,455,100 | 256,237,380 | 203,077,074 |